JBC Biosymposia, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M406546200 on December 3, 2004

J. Biol. Chem., Vol. 280, Issue 7, 6036-6046, February 18, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/7/6036    most recent
M406546200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, W.
Right arrow Articles by Seykora, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, W.
Right arrow Articles by Seykora, J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Srcasm Modulates EGF and Src-kinase Signaling in Keratinocytes*

Weijie Li, Christine Marshall, Lijuan Mei, Leonard Dzubow, Chrysalene Schmults, Michael Dans, and John Seykora{ddagger}

From the Department of Dermatology, University of Pennsylvania Medical School, Philadelphia, Pennsylvania 19104

The Src-activating and signaling molecule (Srcasm) is a recently described activator and substrate of Src-family tyrosine kinases (SFKs). When phosphorylated at specific tyrosines, Srcasm associates with Grb2 and p85, the regulatory subunit of phosphoinositide 3-kinase; however, little is known about the role of Srcasm in cellular signaling. Data presented here demonstrate that epidermal growth factor (EGF) receptor ligands promote the tyrosine phosphorylation of endogenous and adenovirally transduced Srcasm in keratinocytes, and that increased levels of Srcasm activate endogenous SFKs, with a preference for Fyn and Src. In addition, Srcasm potentiates EGF-dependent signals transmitted by SFKs in keratinocytes. Tyrosine phosphorylation of Srcasm is dependent on growth factors and the activity of EGFR and SFKs. Increased Srcasm expression enhances p44/42 mitogen-activated protein kinase activity and Elk-1-dependent transcriptional events. Elevated Srcasm levels inhibit keratinocyte proliferation while promoting specific aspects of keratinocyte differentiation. Lastly, Srcasm levels are decreased in human cutaneous neoplasia. Collectively, these data demonstrate that Srcasm plays a role in linking EGF receptor- and SFK-dependent signaling to differentiation in keratinocytes.


Received for publication, June 11, 2004 , and in revised form, October 12, 2004.

* This work was supported by the University of Pennsylvania and the Department of Dermatology, University of Pennsylvania Medical School, by National Institutes of Health Grants KO8-AR47597 and NCI P01-CA098101, and by a Career Development Award from the Dermatology Foundation (to J. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{ddagger} To whom correspondence should be addressed: Dept. of Dermatology, University of Pennsylvania Medical School, 211a Clinical Research Bldg., 415 Curie Blvd., Philadelphia, PA 19104. Tel.: 215-898-0170; Fax: 215-573-2033; E-mail: john.seykora{at}uphs.upenn.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
S. K. Jung, K. W. Lee, S. Byun, N. J. Kang, S. H. Lim, Y.-S. Heo, A. M. Bode, G. T. Bowden, H. J. Lee, and Z. Dong
Myricetin Suppresses UVB-Induced Skin Cancer by Targeting Fyn
Cancer Res., July 15, 2008; 68(14): 6021 - 6029.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Zhang, K. Suzuki, T. Hitomi, and R. P. Siraganian
TOM1L1 Is a Lyn Substrate Involved in Fc{epsilon}RI Signaling in Mast Cells
J. Biol. Chem., December 28, 2007; 282(52): 37669 - 37677.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
G. Collin, M. Franco, V. Simon, C. Benistant, and S. Roche
The Tom1L1-Clathrin Heavy Chain Complex Regulates Membrane Partitioning of the Tyrosine Kinase Src Required for Mitogenic and Transforming Activities
Mol. Cell. Biol., November 1, 2007; 27(21): 7631 - 7640.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Li, C. Marshall, L. Mei, J. Gelfand, and J. T. Seykora
Srcasm Corrects Fyn-induced Epidermal Hyperplasia by Kinase Down-regulation
J. Biol. Chem., January 12, 2007; 282(2): 1161 - 1169.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. Shiraishi and M. Ascoli
Activation of the Lutropin/Choriogonadotropin Receptor in MA-10 Cells Stimulates Tyrosine Kinase Cascades that Activate Ras and the Extracellular Signal Regulated Kinases (ERK1/2)
Endocrinology, July 1, 2006; 147(7): 3419 - 3427.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. Franco, O. Furstoss, V. Simon, C. Benistant, W. J. Hong, and S. Roche
The Adaptor Protein Tom1L1 Is a Negative Regulator of Src Mitogenic Signaling Induced by Growth Factors.
Mol. Cell. Biol., March 1, 2006; 26(5): 1932 - 1947.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.